Arbutus Biopharma Stock (NASDAQ:ABUS), Quotes and News Summary

Q: What sector and industry does Arbutus Biopharma (ABUS) operate in?

Arbutus Biopharma is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.

Arbutus Biopharma Stock (NASDAQ: ABUS) stock price, news, charts, stock research, profile.

Open	$2.710
Close	$2.710
Volume / Avg.	683.613K / 1.393M
Day Range	2.700 - 2.850
52 Wk Range	1.690 - 3.290
Market Cap	$488.274M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	47
Short Interest	3.25%
Days to Cover	8.81

Recent News

Arbutus Vs. Moderna Patent Dispute Over Covid-19 Vaccine Gets Response From Judge

Delaware Judge favors Arbutus and Genevant Sciences in their patent dispute with Moderna over COVID-19 vaccine technology.

Vandana Singh

Moderna Shares Slip Over Covid Vaccine Patent Dispute, But Chart Signals Potential Rebound Ahead

Moderna stock falls 2.32% due to patent infringement suit. However, some investors see this as an opportunity to enter or average out. Golden Cross formation also offers hope for future growth.

Surbhi Jain

Arbutus Stock Soars 20% As It Heads To Trial With Moderna In Covid Vaccine Patent Claim

Arbutus Biopharma soared more than 20% on Wednesday, April 3, after the company received permission to pursue a claim against Moderna in court.

Neil Dennis

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Mar

Apr

May

Buy

Hold

Sell

Strong Sell

Analyst Rating

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About

Sector

Healthcare

Industry

N/A

Arbutus Biopharma Corp is a biopharmaceutical company. The company discovers, develops, and commerci...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Arbutus Biopharma (ABUS) stock?

You can purchase shares of Arbutus Biopharma (NASDAQ: ABUS) through any online brokerage.

View our list of the best stock brokerages.

Who are Arbutus Biopharma's (ABUS) competitors?

There are no as such competitors for Arbutus Biopharma.

What is the target price for Arbutus Biopharma (ABUS) stock?

The latest price target for Arbutus Biopharma (NASDAQ: ABUS) was reported by Chardan Capital on Friday, May 3, 2024. The analyst firm set a price target for 4.00 expecting ABUS to rise to within 12 months (a possible 47.60% upside). 11 analyst firms have reported ratings in the last year.

Current Stock Price for Arbutus Biopharma (ABUS)?

The stock price for Arbutus Biopharma (NASDAQ: ABUS) is $2.71 last updated May 3, 2024 at 4:00 PM EDT.

Does Arbutus Biopharma (ABUS) pay a dividend?

There are no upcoming dividends for Arbutus Biopharma.

When is Arbutus Biopharma (NASDAQ:ABUS) reporting earnings?

Arbutus Biopharma’s Q2 earnings are confirmed for Thursday, August 1, 2024.

Is Arbutus Biopharma (ABUS) going to split?

There is no upcoming split for Arbutus Biopharma.

What sector and industry does Arbutus Biopharma (ABUS) operate in?

Arbutus Biopharma is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.